Hirmand Mohammad
Insider CIK 1654482 · MDVN Interim Chief Medical Officer · AADI Director · TPTX EVP and Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2026-06-12 | 2026-06-15 | 38,040 | — | $0 | 38,040 | SEC↗ |
| WHWK Whitehawk Therapeutics, In | A Award deriv | 2025-06-12 | 2025-06-16 | 40,006 | — | $0 | 40,006 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 45,832 | — | $0 | 45,832 | SEC↗ |
| AADI Aadi Bioscience, Inc. | A Award deriv | 2023-03-27 | 2023-03-29 | 59,206 | — | $0 | 59,206 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 68,367 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 29,175 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 169,192 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer | 2022-08-17 | 2022-08-17 | 41,284 | $76.00 | $3.14M | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2022-02-09 | 2022-02-11 | 68,367 | — | $0 | 68,367 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2022-02-09 | 2022-02-11 | 18,983 | — | $0 | 25,821 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2022-02-09 | 2022-02-11 | 15,000 | — | $0 | 40,821 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2022-02-09 | 2022-02-11 | 669 | $36.30 | $24.3K | 6,838 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2021-02-08 | 2021-02-10 | 29,175 | — | $0 | 29,175 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2021-02-08 | 2021-02-10 | 6,483 | — | $0 | 6,767 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-01-05 | 2021-01-05 | 1,253 | — | $0 | 169,192 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-05 | 2021-01-05 | 1,253 | $120.00 | $150.4K | 284 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-01-05 | 2021-01-05 | 1,253 | $54.73 | $68.6K | 1,537 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-01-04 | 2021-01-05 | 8,747 | — | $0 | 170,445 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-01-04 | 2021-01-05 | 8,747 | $54.73 | $478.7K | 9,331 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-04 | 2021-01-05 | 300 | $122.44 | $36.7K | 9,031 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-01-04 | 2021-01-05 | 8,747 | $120.42 | $1.05M | 284 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2019-12-02 | 2019-12-03 | 179,192 | — | $0 | 179,192 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 14,474 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 1,120 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 38,530 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 2,380 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 13,560 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 3,460 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 11,740 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 16,880 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 60,000 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 24,000 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 58,800 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer | 2016-09-28 | 2016-09-30 | 18,684 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | U Tender | 2016-09-28 | 2016-09-30 | 39,068 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2016-09-15 | 2016-09-19 | 11,940 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise deriv | 2016-09-15 | 2016-09-19 | 5,620 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2016-09-15 | 2016-09-19 | 5,620 | $4.00 | $22.5K | 45,583 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2016-09-15 | 2016-09-19 | 11,940 | $4.69 | $56.0K | 57,523 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2016-04-08 | 2016-04-08 | 1,120 | — | $0 | 1,120 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-04-06 | 2016-04-08 | 560 | — | $0 | 40,239 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2016-03-04 | 2016-03-07 | 1,525 | $41.10 | $62.7K | 39,342 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2016-02-29 | 2016-03-02 | 38,530 | — | $0 | 38,530 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-02-18 | 2016-03-02 | 9,300 | — | $0 | 40,413 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-12-03 | 2015-12-04 | 1,075 | $43.40 | $46.7K | 31,113 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2015-11-09 | 2015-11-12 | 232 | $41.91 | $9.7K | 32,188 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2015-09-30 | 2015-10-01 | 2,380 | — | $0 | 2,380 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2015-09-29 | 2015-10-01 | 1,190 | — | $0 | 32,420 | SEC↗ |